Provisional Anti-Dumping Measure on Chinese Glass Container Imports
Importers of the affected glass containers must guarantee the payment of the anti-dumping duty for a period of six months from the effective date.
Primary source: Safety monitoring and information
The classification rules for non-invasive medical devices that maintain the patency or flush the lumen of another medical device have been updated.
This update impacts regulatory classification, which could alter labeling and compliance processes for combination products, affecting their marketability and safety oversight.
Review and adjust labeling and compliance processes for affected combination products as per the new regulations.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Review and adjust labeling and compliance processes for affected combination products as per the new regulations.
The TGA has announced updated classification rules that may affect non-invasive medical devices used in combination with other devices, potentially altering their regulatory status.
What changed: The classification rules for non-invasive medical devices that maintain the patency or flush the lumen of another medical device have been updated.
Why it matters: This update impacts regulatory classification, which could alter labeling and compliance processes for combination products, affecting their marketability and safety oversight.
Practical implication: Review and adjust labeling and compliance processes for affected combination products as per the new regulations.
Published from the regulator source ingestion pipeline after PV impact triage.
Importers of the affected glass containers must guarantee the payment of the anti-dumping duty for a period of six months from the effective date.
Monitor and possibly revise compliance reporting processes to reflect new regulatory expectations stemming from the fine imposed on United Utilities Limited.
Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.
Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.